International Stem Cell (OTCMKTS:ISCO) Share Price Passes Above 200-Day Moving Average – Should You Sell?

International Stem Cell Corp. (OTCMKTS:ISCO) crossed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $0.14 and traded as high as $0.1750. International Stem Cell shares last traded at $0.1750, with a volume of 192 shares.

International Stem Cell Stock Performance

The business has a 50-day simple moving average of $0.15 and a two-hundred day simple moving average of $0.14. The company has a market capitalization of $1.40 million, a price-to-earnings ratio of -8.75 and a beta of 0.24.

International Stem Cell Company Profile

International Stem Cell Corporation (OTCMKTS:ISCO) is a biotechnology company focused on the development and commercialization of human parthenogenetic stem cells (hpSC) for therapeutic and research applications. Parthenogenetic stem cells are derived from unfertilized human eggs and offer a scalable, ethically noncontroversial source of pluripotent cells. ISCO’s proprietary hpSC lines can be directed to differentiate into a wide variety of cell types, enabling preclinical programs in areas such as neurodegenerative disease, liver disease, diabetes and corneal regeneration.

In addition to its therapeutic pipeline, International Stem Cell maintains a research products division that supplies hpSC lines, differentiated cell populations and media formulations to academic institutions, biotechnology companies and contract research organizations.